<SEC-DOCUMENT>0001878313-26-000069.txt : 20260702
<SEC-HEADER>0001878313-26-000069.hdr.sgml : 20260702
<ACCEPTANCE-DATETIME>20260702160921
ACCESSION NUMBER:		0001878313-26-000069
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260630
FILED AS OF DATE:		20260702
DATE AS OF CHANGE:		20260702

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Theagene Jean-Manasse
		CENTRAL INDEX KEY:			0001969857
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41455
		FILM NUMBER:		261151192

	MAIL ADDRESS:	
		STREET 1:		500 PLACE D ARMES
		STREET 2:		SUITE 1800
		CITY:			MONTREAL
		STATE:			MT
		ZIP:			H2Y 2W2

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MAIA Biotechnology, Inc.
		CENTRAL INDEX KEY:			0001878313
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		444 WEST LAKE STREET, SUITE 1700
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-416-8592

	MAIL ADDRESS:	
		STREET 1:		444 WEST LAKE STREET, SUITE 1700
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>PRIMARY DOCUMENT
</DOCUMENT>
</SUBMISSION>